Enfermedades retinianas y nuevas terapias
University of Zurich
Zúrich, SuizaPublicaciones en colaboración con investigadores/as de University of Zurich (1)
2024
-
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2
Ophthalmology, Vol. 131, Núm. 8, pp. 914-926